SCHEMBL28486277

SCHEMBL28486277

C=C(C)CCNCCCCC(N)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.46
NOS2 P35228 6/20 0.45
NOS1 P29475 4/20 0.45
NOS3 P29474 3/20 0.45
CYP1A2 P05177 3/20 0.45
TSHR P16473 2/20 0.45
CYP3A4 P08684 1/20 0.45
BLM P54132 1/20 0.44
CYP2C19 P33261 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ARG2 P78540 4/20 0.42
ARG1 P05089 3/20 0.42
GLA P06280 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41
GRM8 O00222 1/20 0.40
GRM6 O15303 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21335953 0.85 GSR (0.47) GSRNOS2NOS1NOS3CYP1A2
SCHEMBL29485083 0.84 GSR (0.61) GSRNOS2NOS1NOS3CYP1A2
SCHEMBL359142 0.83 GSR (0.55) GSRCYP1A2BLMKMT2AARG2
SCHEMBL2263990 0.83 GSR (0.55) GSRCYP1A2BLMKMT2AARG2
SCHEMBL2263983 0.83 GSR (0.55) GSRCYP1A2BLMKMT2AARG2
SCHEMBL10187368 0.81 GSR (0.52) GSRNOS2NOS1NOS3CYP1A2
SCHEMBL10187360 0.80 NOS2 (0.45) GSRNOS2NOS1NOS3CYP1A2
SCHEMBL25227671 0.80 GSR (0.52) GSRNOS2NOS1NOS3CYP1A2
SCHEMBL9362560 0.80 GRIK1 (0.56) GSRTSHRARG2ARG1GRIK1
SCHEMBL10285774 0.80 NOD1 (0.52) GSRNOS1ARG2ARG1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116121275-B Acquisition and application of liver targeting novel adeno-associated virus 北京三诺佳邑生物技术有限责任公司 2024-11-29 CN disclosed
CN-116121274-B Acquisition and application of liver targeting novel adeno-associated virus 北京三诺佳邑生物技术有限责任公司 2024-11-19 CN disclosed
CN-115927398-B Acquisition and application of liver targeting novel adeno-associated virus 北京三诺佳邑生物技术有限责任公司 2024-11-19 CN disclosed
CN-115960921-B Acquisition and application of liver targeting novel adeno-associated virus 北京三诺佳邑生物技术有限责任公司 2024-10-22 CN disclosed
CN-116121274-A Acquisition and application of liver targeting novel adeno-associated virus 北京三诺佳邑生物技术有限责任公司 2023-05-16 CN disclosed
CN-116121275-A Acquisition and application of liver targeting novel adeno-associated virus 北京三诺佳邑生物技术有限责任公司 2023-05-16 CN disclosed
CN-115960921-A Acquisition and application of novel liver-targeted adeno-associated viruses 舒泰神(北京)生物制药股份有限公司 2023-04-14 CN disclosed
CN-115927398-A Acquisition and application of novel liver-targeted adeno-associated viruses 舒泰神(北京)生物制药股份有限公司 2023-04-07 CN disclosed
CN-111876432-B Acquisition and application of novel liver-targeted adeno-associated viruses 舒泰神(北京)生物制药股份有限公司 2022-10-28 CN disclosed
CN-111876432-A Acquisition and application of novel liver-targeted adeno-associated viruses 舒泰神(北京)生物制药股份有限公司 2020-11-03 CN disclosed